Workflow
康帕斯集团(CMPGY)
icon
搜索文档
All You Need to Know About Compass Group (CMPGY) Rating Upgrade to Buy
ZACKS· 2024-09-12 01:00
Compass Group PLC (CMPGY) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate. Since a changin ...
Compass CEO & Founder Robert Reffkin to Speak at Zelman Housing Summit
Prnewswire· 2024-09-05 04:30
文章核心观点 - 公司是美国最大的住宅房地产经纪公司,销售量第一 [1][3] - 公司CEO将在Zelman Housing Summit上发表演讲,并将通过网络直播的方式进行 [1] 公司概况 - 公司成立于2012年,总部位于纽约,为房地产经纪人提供端到端的云端软件平台 [2] - 该平台包括客户关系管理、营销、客户服务、经纪服务等关键功能 [2] - 该平台帮助经纪人提高业务增长、节省时间和更有效地管理业务 [2]
Toronto Hospitality Experts The Food Dudes Announce Exclusive Partnership with Nation's Leading Food Service Provider, Compass Group Canada
GlobeNewswire News Room· 2024-09-03 20:45
文章核心观点 - 加拿大领先的餐饮和支持服务提供商Compass Group Canada与著名的餐饮公司The Food Dudes达成独家合作伙伴关系 [1][2][3] - 这一合作标志着The Food Dudes将其独特产品的前沿风格与Compass Group Canada的广泛运营能力和行业专业知识相结合 [1][2][3] - 双方的合作旨在扩大The Food Dudes的影响力,提升其产品和服务水平,共同推动行业发展,创造难忘的体验 [3][4] 公司概况 The Food Dudes - The Food Dudes成立于2009年,由主厨Adrian Niman创立,在多伦多最负盛名的场所和活动中提供出色的餐饮体验 [2][5] - The Food Dudes以创意菜单和在原创餐厅如Pantry、Rasa和Sara的动态呈现而闻名,在加拿大餐饮业中树立了先驱地位 [2][5] - The Food Dudes的创始人Adrian Niman和CEO Lindsay Klein将继续领导公司的日常运营 [3] Compass Group Canada - Compass Group Canada是加拿大领先的餐饮和支持服务提供商,在全国拥有2,100个地点,雇佣2.5万多名员工 [6] - Compass Group Canada的专业涵盖多个领域,包括体育场馆、餐厅、学校、医院、油田、远程营地、自动售货服务和设施管理等 [6] - Compass Group Canada致力于成为加拿大最具创新的餐饮服务提供商,通过前沿技术和前瞻性方法来重塑行业 [6] - Compass Group Canada获得了多项殊荣,如"加拿大最受赞赏企业文化"和"加拿大最佳工作场所" [7]
Compass Therapeutics to Participate in Upcoming Investor Events
GlobeNewswire News Room· 2024-09-03 20:00
BOSTON, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinicalstage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the following investor events during the month of September 2024. Details are as follows: H.C. Wainwright 26th Annual Global Investment Conference Location: New York, NY Date: Monday, September 9, 2024 Time: 11:00am ET Webcast L ...
Compass Pathways to participate in three investor conferences in September
GlobeNewswire News Room· 2024-08-28 18:00
LONDON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in the following September investor conferences: Morgan Stanley 22nd Annual Global Healthcare Conference: fireside chat at 7:45 am ET on September 4, 2024, and host investor meetings H. C. Wainwright 26th Annual Global Investment Conference: fireside chat at 9:30 am ET on ...
Compass: Amid Market Share Gains And NAR Ruling Confidence, This Stock Is A Buy
Seeking Alpha· 2024-08-28 06:20
文章核心观点 - 房地产行业正经历巨大变革 [8] - 领先经纪公司Compass正在快速增长 [9][10] - Compass CEO认为NAR裁决对经纪人佣金影响有限 [11] - Compass Q2业绩表现强劲 [12][13][14] 公司表现 - Compass收入同比增长14%至17亿美元 [12] - Compass市场份额提升至5.13% [12] - Compass交易量同比增长11% [12] - Compass调整后EBITDA同比翻倍至7740万美元 [14] - Compass正在积极扩张并提高运营效率 [12][13][14] 行业动态 - 房地产行业受利率上升和房源减少影响 [10] - NAR裁决要求买家代理佣金信息透明化 [11] - 买家可能会更多谈判佣金 [11] - 房价持续高企可能限制行业复苏 [15]
Compass Diversified Announces Stephen Keller as Chief Financial Officer
GlobeNewswire News Room· 2024-08-26 18:00
WESTPORT, Conn., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) ("CODI" or the "Company"), an owner of leading middle market businesses, announced today that Stephen Keller has been appointed as the Company's Chief Financial Officer (CFO), effective August 31, 2024. He will be replacing Ryan Faulkingham, who has served as the Company's CFO since July 2013 and is departing the Company effective August 30, 2024. Mr. Faulkingham will continue to serve in an advisory capacity in order to fac ...
Compass Diversified-Backed Altor Solutions to Acquire Lifoam Industries
GlobeNewswire News Room· 2024-08-19 20:00
WESTPORT, Conn., Aug. 19, 2024 (GLOBE NEWSWIRE) -- Altor Solutions ("Altor"), a subsidiary of Compass Diversified (NYSE: CODI) and a leading designer and manufacturer of custom protective and coldchain packaging solutions for the industrial and life sciences markets, today announced it has entered into a definitive agreement to acquire Lifoam Industries, LLC ("Lifoam"), a manufacturer and distributor of temperature-controlled shipping solutions, for an enterprise value of $137 million in cash at closing (ex ...
Compass CEO & Founder Robert Reffkin to Present at Oppenheimer's 27th Annual Technology, Internet & Communications Conference
Prnewswire· 2024-08-09 04:30
NEW YORK, Aug. 8, 2024 /PRNewswire/ -- Compass, Inc. (NYSE: COMP) ("Compass" or "the Company"), the largest residential real estate company in the United States by sales volume[1], announces that its CEO & Founder Robert Reffkin will participate in Oppenheimer's 27th Annual Technology, Internet & Communications Conference. The virtual event is scheduled for Tuesday, August 13, 2024. Compass Chief Financial Officer Kalani Reelitz and Chief Accounting Officer Scott Wahlers will join Reffkin. Reffkin and the t ...
Compass Therapeutics to Participate in the Wedbush PacGrow Healthcare Conference
GlobeNewswire News Room· 2024-08-07 20:00
BOSTON, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinicalstage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will present at the Wedbush PacGrow Healthcare Conference taking place in New York City, New York on Tuesday, August 13, 2024, at 11 AM ET. About Compass Therapeutics Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical ...